24
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations

      research-article
      , MD , , MD, , MD, PhD, , MD, PhD, , MD, , MD, , MD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, PhD, , MD, PhD, , MD, , MD, PhD, , MD, , MD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, On behalf of the CoCo Neurosciences study group
      Radiology
      Radiological Society of North America
      COVID-19, SARS-CoV-2, neurological manifestations, brain MRI, imaging patterns

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          This study provides a detailed imaging assessment in a large series of COVID-19 patients with neurological manifestations.

          Purpose

          To review the MRI findings associated with acute neurological manifestations in COVID-19 patients.

          Methods

          This was a cross-sectional study conducted between March 23 and May 7, 2020 at the Pitié-Salpêtrière University Hospital, a reference center for COVID-19 in the Paris area. Inclusion criteria were: adult patients diagnosed with SARS-CoV-2 infection, presenting with acute neurological manifestations and referred for a brain MRI examination. Patients were excluded if they had a previous history of neurological disease. The characteristics and the frequency of different MRI features were investigated. The findings were analyzed separately in patients in intensive care units (ICU) and other departments (non-ICU).

          Results

          During the inclusion period, 1176 consecutive patients were hospitalized for suspected COVID-19. Out of 308 patients with acute neurological symptoms, 73 patients met the inclusion criteria (23.7%) and were included: 35 ICU patients (47.9%) and 38 non-ICU patients (52.1%). The mean age was 58.5 ± 15.6 years, with a male predominance (65.8% vs. 34.2%). Forty-three patients presented pathological MRI findings 2-4 weeks after symptom onset (58.9%), including 17 with acute ischemic infarct (23.3%), 1 with a deep venous thrombosis (1.4%), 8 with multiple microhemorrhages (11.3%), 22 with perfusion abnormalities (47.7%), 3 with restricted diffusion foci within the corpus callosum consistent with cytotoxic lesions of the corpus callosum (CLOCC, 4.1%). Multifocal white matter enhancing lesions were seen in 4 ICU patients (5%). Basal ganglia abnormalities were seen in 4 other patients (5%). The cerebrospinal fluid (CSF) analysis was negative for SARS-CoV-2 in all tested patients (n=39).

          Conclusion

          In addition to cerebrovascular lesions, perfusion abnormalities, CLOCC and ICU-related complications, we identified two patterns including white matter enhancing lesions and basal ganglia abnormalities that could be related to SARS-CoV-2 infection.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Endothelial cell infection and endotheliitis in COVID-19

          Cardiovascular complications are rapidly emerging as a key threat in coronavirus disease 2019 (COVID-19) in addition to respiratory disease. The mechanisms underlying the disproportionate effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on patients with cardiovascular comorbidities, however, remain incompletely understood.1, 2 SARS-CoV-2 infects the host using the angiotensin converting enzyme 2 (ACE2) receptor, which is expressed in several organs, including the lung, heart, kidney, and intestine. ACE2 receptors are also expressed by endothelial cells. 3 Whether vascular derangements in COVID-19 are due to endothelial cell involvement by the virus is currently unknown. Intriguingly, SARS-CoV-2 can directly infect engineered human blood vessel organoids in vitro. 4 Here we demonstrate endothelial cell involvement across vascular beds of different organs in a series of patients with COVID-19 (further case details are provided in the appendix). Patient 1 was a male renal transplant recipient, aged 71 years, with coronary artery disease and arterial hypertension. The patient's condition deteriorated following COVID-19 diagnosis, and he required mechanical ventilation. Multisystem organ failure occurred, and the patient died on day 8. Post-mortem analysis of the transplanted kidney by electron microscopy revealed viral inclusion structures in endothelial cells (figure A, B ). In histological analyses, we found an accumulation of inflammatory cells associated with endothelium, as well as apoptotic bodies, in the heart, the small bowel (figure C) and lung (figure D). An accumulation of mononuclear cells was found in the lung, and most small lung vessels appeared congested. Figure Pathology of endothelial cell dysfunction in COVID-19 (A, B) Electron microscopy of kidney tissue shows viral inclusion bodies in a peritubular space and viral particles in endothelial cells of the glomerular capillary loops. Aggregates of viral particles (arrow) appear with dense circular surface and lucid centre. The asterisk in panel B marks peritubular space consistent with capillary containing viral particles. The inset in panel B shows the glomerular basement membrane with endothelial cell and a viral particle (arrow; about 150 nm in diameter). (C) Small bowel resection specimen of patient 3, stained with haematoxylin and eosin. Arrows point to dominant mononuclear cell infiltrates within the intima along the lumen of many vessels. The inset of panel C shows an immunohistochemical staining of caspase 3 in small bowel specimens from serial section of tissue described in panel D. Staining patterns were consistent with apoptosis of endothelial cells and mononuclear cells observed in the haematoxylin-eosin-stained sections, indicating that apoptosis is induced in a substantial proportion of these cells. (D) Post-mortem lung specimen stained with haematoxylin and eosin showed thickened lung septa, including a large arterial vessel with mononuclear and neutrophilic infiltration (arrow in upper inset). The lower inset shows an immunohistochemical staining of caspase 3 on the same lung specimen; these staining patterns were consistent with apoptosis of endothelial cells and mononuclear cells observed in the haematoxylin-eosin-stained sections. COVID-19=coronavirus disease 2019. Patient 2 was a woman, aged 58 years, with diabetes, arterial hypertension, and obesity. She developed progressive respiratory failure due to COVID-19 and subsequently developed multi-organ failure and needed renal replacement therapy. On day 16, mesenteric ischaemia prompted removal of necrotic small intestine. Circulatory failure occurred in the setting of right heart failure consequent to an ST-segment elevation myocardial infarction, and cardiac arrest resulted in death. Post-mortem histology revealed lymphocytic endotheliitis in lung, heart, kidney, and liver as well as liver cell necrosis. We found histological evidence of myocardial infarction but no sign of lymphocytic myocarditis. Histology of the small intestine showed endotheliitis (endothelialitis) of the submucosal vessels. Patient 3 was a man, aged 69 years, with hypertension who developed respiratory failure as a result of COVID-19 and required mechanical ventilation. Echocardiography showed reduced left ventricular ejection fraction. Circulatory collapse ensued with mesenteric ischaemia, and small intestine resection was performed, but the patient survived. Histology of the small intestine resection revealed prominent endotheliitis of the submucosal vessels and apoptotic bodies (figure C). We found evidence of direct viral infection of the endothelial cell and diffuse endothelial inflammation. Although the virus uses ACE2 receptor expressed by pneumocytes in the epithelial alveolar lining to infect the host, thereby causing lung injury, the ACE2 receptor is also widely expressed on endothelial cells, which traverse multiple organs. 3 Recruitment of immune cells, either by direct viral infection of the endothelium or immune-mediated, can result in widespread endothelial dysfunction associated with apoptosis (figure D). The vascular endothelium is an active paracrine, endocrine, and autocrine organ that is indispensable for the regulation of vascular tone and the maintenance of vascular homoeostasis. 5 Endothelial dysfunction is a principal determinant of microvascular dysfunction by shifting the vascular equilibrium towards more vasoconstriction with subsequent organ ischaemia, inflammation with associated tissue oedema, and a pro-coagulant state. 6 Our findings show the presence of viral elements within endothelial cells and an accumulation of inflammatory cells, with evidence of endothelial and inflammatory cell death. These findings suggest that SARS-CoV-2 infection facilitates the induction of endotheliitis in several organs as a direct consequence of viral involvement (as noted with presence of viral bodies) and of the host inflammatory response. In addition, induction of apoptosis and pyroptosis might have an important role in endothelial cell injury in patients with COVID-19. COVID-19-endotheliitis could explain the systemic impaired microcirculatory function in different vascular beds and their clinical sequelae in patients with COVID-19. This hypothesis provides a rationale for therapies to stabilise the endothelium while tackling viral replication, particularly with anti-inflammatory anti-cytokine drugs, ACE inhibitors, and statins.7, 8, 9, 10, 11 This strategy could be particularly relevant for vulnerable patients with pre-existing endothelial dysfunction, which is associated with male sex, smoking, hypertension, diabetes, obesity, and established cardiovascular disease, all of which are associated with adverse outcomes in COVID-19.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

            The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, is serious and has the potential to become an epidemic worldwide. Several studies have described typical clinical manifestations including fever, cough, diarrhea, and fatigue. However, to our knowledge, it has not been reported that patients with COVID-19 had any neurologic manifestations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

              Little evidence of increased thrombotic risk is available in COVID-19 patients. Our purpose was to assess thrombotic risk in severe forms of SARS-CoV-2 infection.
                Bookmark

                Author and article information

                Contributors
                Journal
                Radiology
                Radiology
                Radiology
                Radiology
                Radiological Society of North America
                0033-8419
                1527-1315
                17 July 2020
                : 202422
                Affiliations
                [1]Sorbonne Université, Inserm, CNRS, Institut du Cerveau - Paris Brain Institute - ICM, F-75013, Paris, France (L.C., D.G., B.M., C.R., D.D., J.C., S.L., N.P.); Sorbonne Université, 75013, Paris, France (L.C., N.S., N.W., D.G., B.M., S.B., D.B., A.D., C.R., D.S., D.D., E.M., M.R., T.S., V.D., J.C., S.L., N.P.); ICM, “Movement Investigations and Therapeutics” Team (MOV’IT), Paris, France (L.C., S.L., N.P.); ICM, Centre de NeuroImagerie de Recherche – CENIR, Paris, France (L.C., D.G., S.L., N.P.); Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Service de neuroradiologie, Paris, France (L.C., N.S., D.G., D.L., S.B., S.S., D.D., S.G., S.T., S.L., N.P.); Brain Liver Pitié-Salpêtrière (BLIPS) Study Group, INSERM UMR_S 938, Centre de recherche Saint-Antoine, Maladies métaboliques, biliaires et fibro-inflammatoire du foie, Institute of Cardiometabolism and Nutrition (ICAN) (N.W., S.D.); Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Médecine Intensive Réanimation Neurologique, Paris, France (N.W.); Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Service de neurochirurgie, Paris, France (B.M.); Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Service de virologie, Centre d’Investigation Clinique Neurosciences, Paris, France (S.B., D.B.); CNR Herpèsvirus (laboratoire associé HSV), SU-INSERM UMR_S 1136 Team 3 THERAVIR IPLESP (S.B., D.B.); Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Service de Pneumologie, Médecine Intensive et Réanimation, Paris, France (A.D., E.M., T.S.); Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Urgences Cérébro-Vasculaires, Paris, France (C.R.); ICM, stroke network, STAR team, Paris, France (C.R.); Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Département de Neurologie, Centre d’Investigation Clinique Neurosciences, Paris, France (C.D., J.C.); Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Département de Neuropathologie, Paris, France (D.S.); ICM, INRIA, ARAMIS project-team, Paris, France (D.D., M.R., M.R.); Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Anesthesia, Critical Care and Peri-Operative Medicine, Paris, France (M.R., V.D.); Clinical Research Group ARPE, Sorbonne University, Paris, France (V.D.); INSERM UMR 1141, Paris France (V.D.); Assistance Publique Hôpitaux de Paris, DMU ESPRIT, Paris, France(P.R.)
                Author notes
                Corresponding Author Contact Details: C.L Email: chougar.lydia@ 123456gmail.com
                Author information
                https://orcid.org/0000-0001-9306-5687
                https://orcid.org/0000-0003-0693-1829
                https://orcid.org/0000-0001-5155-196X
                https://orcid.org/0000-0002-9285-8121
                https://orcid.org/0000-0003-1110-3833
                https://orcid.org/0000-0002-9182-5846
                https://orcid.org/0000-0002-3634-912X
                https://orcid.org/0000-0002-7783-2601
                https://orcid.org/0000-0001-9401-4662
                https://orcid.org/0000-0002-0432-7217
                https://orcid.org/0000-0001-7236-1508
                https://orcid.org/0000-0002-5838-9077
                https://orcid.org/0000-0003-3498-4602
                https://orcid.org/0000-0002-6080-1286
                https://orcid.org/0000-0002-1323-6819
                https://orcid.org/0000-0003-2493-9146
                https://orcid.org/0000-0002-0523-6472
                https://orcid.org/0000-0002-1901-8126
                https://orcid.org/0000-0003-3825-7699
                https://orcid.org/0000-0003-2868-9279
                https://orcid.org/0000-0002-6540-5725
                https://orcid.org/0000-0002-2222-4369
                https://orcid.org/0000-0001-7325-0199
                https://orcid.org/0000-0002-5802-3518
                https://orcid.org/0000-0002-2070-1299
                Article
                202422
                10.1148/radiol.2020202422
                7370354
                32677875
                1e288654-e70c-41d8-a66d-f977f0e6571e
                2020 by the Radiological Society of North America, Inc.

                This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                Categories
                Original Research

                covid-19,sars-cov-2,neurological manifestations,brain mri,imaging patterns

                Comments

                Comment on this article